Accessibility Menu
Canopy Growth logo

Canopy Growth(TSX) WEED

Market CapCA$604.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-94%
5 Year-99%
1 Year-17%
1 Month+9%
CA$1.41
-1.40%
-0.02Today
Canopy Growth last closing stock price
MetricPriceDate
Last closeCAD 1.432026-08-19
Canopy Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.7%CAD 1.422026-08-12
1 month+9.16%CAD 1.312026-07-20
3 month-4.03%CAD 1.492026-05-21
Year to date-8.33%CAD 1.562025-12-31
1 year-17.34%CAD 1.732025-08-19
3 year-76.94%CAD 6.202023-08-18
5 year-99.33%CAD 213.702021-08-20
Since inception-94.48%CAD 25.902014-04-04

Canopy Growth Financials at a Glance

Market Cap

CA$604.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$319.96M

Net Income (TTM)

-CA$236.61M

EPS (TTM)

-CA$0.62

P/E Ratio

-2.29

Dividend

CA$0.00

Beta (Volatility)

2.29 (High)

Price

CA$1.41

Volume

334,234

Open

CA$1.43

Previous Close

CA$1.43

Daily Range

CA$1.40 - CA$1.43

52-Week Range

CA$1.18 - CA$3.28

Estimated Earnings Date

Nov 6, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Canopy Growth

Canopy Growth Corporation is a leading player in the cannabis industry, focusing on the cultivation, marketing, and distribution of cannabis and hemp-derived products. The company serves both recreational and medical markets across Canada, the United States, and Germany, with a diverse portfolio of well-known brands.

Products and Services
  • Dried cannabis flower and a variety of extracts
  • Beverages, edible gummies, and vaporization products
  • Medical cannabis solutions under Spectrum Therapeutics
Growth Outlook
  • Recent quarterly revenue reached CAD 81.2 million, showing a positive trend
  • Strong market presence in Canada and expanding into the U.S. and Germany
  • Innovative product launches expected to drive future sales growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 292.5 million
  • Current ratio of 3.04 indicates strong liquidity position
  • Net income for the latest quarter was CAD -14.6 million, reflecting ongoing challenges
Canopy Growth Corporation has established itself as a significant entity in the cannabis sector, with a comprehensive range of products catering to various consumer needs. The company's recent revenue growth and strong liquidity position suggest potential for future expansion. However, challenges remain, as indicated by the net income figures. Investors may find the company's strategic initiatives and market positioning noteworthy as it navigates the evolving landscape of the cannabis industry.
AI Generated • Aug 19, 2026

Industry

Pharmaceuticals

Employees

1,128

CEO

Luc Mongeau

Headquarters

Smiths Falls, ON K7A 0A8, CA

WEED Financials

Key Financial Metrics (TTM)

Gross Margin

22.87%

Operating Margin

-46.89%

Net Income Margin

-73.95%

Return on Equity

-29.85%

Return on Capital

-7.49%

Return on Assets

-21.43%

Earnings Yield

-43.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$604.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

423.04M

Volume

334.23K

Avg. Volume

1.08M

Financials (TTM)

Gross Profit

CA$73.17M

Operating Income

-CA$150.03M

EBITDA

-CA$33.65M

Operating Cash Flow

-CA$85.58M

Capital Expenditure

-CA$5.69M

Free Cash Flow

-CA$91.26M

Cash & ST Invst.

CA$336.63M

Total Debt

CA$277.33M

Canopy Growth Performance Analysis

Canopy Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 333,253,000-34.7%
20242024-03-31CAD 297,146,000-10.8%
20252025-03-31CAD 268,995,000-9.5%
20262026-03-31CAD 284,603,0005.8%
Canopy Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3028.9%
Q32025-12-31-19.9%
Q42026-03-31-4.4%
Q12026-06-3013.9%
Canopy Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -70.69792.2%
20242024-03-31CAD -8.79-87.6%
20252025-03-31CAD -4.73-46.2%
20262026-03-31CAD -0.88-81.4%
Canopy Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3096.2%
Q32025-12-31-2042.9%
Q42026-03-31-150.0%
Q12026-06-3093.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

CA$81.17M

+12.5%

Gross Profit

CA$22.24M

+23.3%

Gross Margin

27.40%

N/A

Market Cap

CA$604.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$536.30K

N/A

Employees

1,128

N/A

Net Income

-CA$14.58M

+64.9%

EBITDA

CA$8.00M

+136.7%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

CA$336.63M

+134.4%

Total Debt

CA$277.33M

-15.4%

Accounts Receivable

CA$42.59M

-14.9%

Inventory

CA$107.46M

+14.5%

Long Term Debt

CA$234.26M

-24.2%

Short Term Debt

CA$43.07M

+127.6%

Return on Assets

-21.43%

N/A

Return on Invested Capital

-16.01%

N/A

Free Cash Flow

-CA$25.75M

-117.7%

Operating Cash Flow

-CA$25.01M

-142.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NGEN.VNervGen Pharma Corp.
CA$5.15+3.00%
CPH.TOCipher Pharmaceuticals Inc.
CA$14.26-0.70%
ACB.TOAurora Cannabis Inc.
CA$5.18-3.54%
XLY.TOAuxly Cannabis Group Inc.
CA$3.15-2.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.82+0.06%
IBITiShares Bitcoin Trust
$41.14+0.06%
SPCXSpace Exploration Technologies
$130.84-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.80-0.04%

Questions About WEED

What is the current price of Canopy Growth?

Canopy Growth is trading at CA$1.41 per share.

What is the 52-week range for Canopy Growth?

Over the past 52 weeks, Canopy Growth has traded between CA$1.18 and CA$3.28.

How much debt does Canopy Growth have?

As of the most recent reporting period, Canopy Growth reported total debt of CA$277.33M.

How much cash does Canopy Growth have on hand?

Canopy Growth reported CA$336.63M in cash and cash equivalents in its most recent financial results.

What is Canopy Growth’s dividend yield?

Canopy Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.